
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PB | 956 | 68.7% | -1.52 | 334 | 86.1% |
| EB | 256 | 18.4% | -5.42 | 6 | 1.5% |
| bL(R) | 101 | 7.3% | -2.27 | 21 | 5.4% |
| CentralBrain-unspecified | 44 | 3.2% | -0.70 | 27 | 7.0% |
| FB | 24 | 1.7% | -inf | 0 | 0.0% |
| CRE(R) | 10 | 0.7% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns EPGt | % In | CV |
|---|---|---|---|---|---|
| Delta7 (R) | 5 | Glu | 248.5 | 36.5% | 0.3 |
| P6-8P9 (L) | 2 | Glu | 103.5 | 15.2% | 0.0 |
| LPsP (L) | 1 | ACh | 48 | 7.0% | 0.0 |
| EPG (L) | 5 | ACh | 37.5 | 5.5% | 1.4 |
| LPsP (R) | 1 | ACh | 35.5 | 5.2% | 0.0 |
| ExR6 (R) | 1 | Glu | 19 | 2.8% | 0.0 |
| ER3p_a (L) | 7 | GABA | 14.5 | 2.1% | 0.5 |
| PEN_b(PEN2) (L) | 2 | ACh | 12.5 | 1.8% | 0.9 |
| EPG (R) | 2 | ACh | 12.5 | 1.8% | 0.2 |
| EPGt (L) | 2 | ACh | 11.5 | 1.7% | 0.1 |
| PEN_b(PEN2) (R) | 1 | ACh | 11.5 | 1.7% | 0.0 |
| IbSpsP (L) | 2 | ACh | 11.5 | 1.7% | 0.1 |
| ER3p_a (R) | 5 | GABA | 10 | 1.5% | 0.5 |
| PEN_a(PEN1) (L) | 2 | ACh | 8.5 | 1.2% | 0.5 |
| ExR6 (L) | 1 | Glu | 7.5 | 1.1% | 0.0 |
| PEG (L) | 2 | ACh | 7.5 | 1.1% | 0.9 |
| PEN_a(PEN1) (R) | 2 | ACh | 7.5 | 1.1% | 0.2 |
| OA-AL2i1 (L) | 1 | unc | 6 | 0.9% | 0.0 |
| SpsP (L) | 2 | Glu | 6 | 0.9% | 0.2 |
| ER1_a (L) | 4 | GABA | 5.5 | 0.8% | 0.2 |
| ExR4 (R) | 1 | Glu | 4.5 | 0.7% | 0.0 |
| Delta7 (L) | 2 | Glu | 4 | 0.6% | 0.5 |
| ER3w_b (L) | 6 | GABA | 4 | 0.6% | 0.4 |
| SMP371_a (R) | 1 | Glu | 3.5 | 0.5% | 0.0 |
| PFNv (L) | 1 | ACh | 3.5 | 0.5% | 0.0 |
| ER3w_b (R) | 3 | GABA | 3 | 0.4% | 0.7 |
| PFNp_a (L) | 2 | ACh | 2.5 | 0.4% | 0.6 |
| ER3p_b (L) | 2 | GABA | 2 | 0.3% | 0.5 |
| ER3p_b (R) | 2 | GABA | 2 | 0.3% | 0.5 |
| hDeltaI (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| ExR1 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| ER1_a (R) | 2 | GABA | 2 | 0.3% | 0.0 |
| hDeltaB (R) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| FB4Y (R) | 2 | 5-HT | 1.5 | 0.2% | 0.3 |
| ER3w_c (L) | 1 | GABA | 1.5 | 0.2% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1.5 | 0.2% | 0.0 |
| ER1_b (R) | 2 | GABA | 1.5 | 0.2% | 0.3 |
| FB4F_c (R) | 2 | Glu | 1 | 0.1% | 0.0 |
| ExR7 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PFR_a (R) | 1 | unc | 1 | 0.1% | 0.0 |
| PEG (R) | 2 | ACh | 1 | 0.1% | 0.0 |
| FB5H (R) | 1 | DA | 0.5 | 0.1% | 0.0 |
| FB1H (R) | 1 | DA | 0.5 | 0.1% | 0.0 |
| FB1H (L) | 1 | DA | 0.5 | 0.1% | 0.0 |
| hDeltaA (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| CRE055 (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| FB5E (R) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| hDeltaJ (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FC1D (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FB5M (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| FB4F_c (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| EL (L) | 1 | OA | 0.5 | 0.1% | 0.0 |
| ExR4 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| FB4Z_a (R) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| PAM09 (R) | 1 | DA | 0.5 | 0.1% | 0.0 |
| FB4Z_b (R) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| PFR_b (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FC2C (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FC3_a (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| ER1_b (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| SMP371_b (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| ER3w_c (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| downstream partner | # | NT | conns EPGt | % Out | CV |
|---|---|---|---|---|---|
| PFNd (L) | 2 | ACh | 87 | 13.8% | 0.1 |
| PEG (L) | 1 | ACh | 85.5 | 13.6% | 0.0 |
| Delta7 (L) | 16 | Glu | 61 | 9.7% | 0.8 |
| Delta7 (R) | 15 | Glu | 58 | 9.2% | 0.8 |
| LPsP (L) | 1 | ACh | 39.5 | 6.3% | 0.0 |
| PFNa (L) | 3 | ACh | 35.5 | 5.6% | 0.1 |
| LPsP (R) | 1 | ACh | 30 | 4.8% | 0.0 |
| IbSpsP (L) | 3 | ACh | 24 | 3.8% | 0.6 |
| PEN_b(PEN2) (L) | 2 | ACh | 23.5 | 3.7% | 0.3 |
| PFNp_c (L) | 3 | ACh | 22 | 3.5% | 0.1 |
| PFNv (L) | 1 | ACh | 20 | 3.2% | 0.0 |
| PEN_a(PEN1) (L) | 1 | ACh | 17 | 2.7% | 0.0 |
| PFNp_e (L) | 2 | ACh | 14.5 | 2.3% | 0.2 |
| EPGt (L) | 2 | ACh | 11.5 | 1.8% | 0.1 |
| PFNp_a (L) | 4 | ACh | 10.5 | 1.7% | 0.6 |
| PFNp_b (L) | 7 | ACh | 8 | 1.3% | 0.7 |
| ExR1 (R) | 2 | ACh | 7 | 1.1% | 0.7 |
| FR1 (L) | 1 | ACh | 6.5 | 1.0% | 0.0 |
| EPG (L) | 5 | ACh | 6 | 1.0% | 1.2 |
| PFGs (L) | 1 | unc | 4.5 | 0.7% | 0.0 |
| ExR6 (R) | 1 | Glu | 4.5 | 0.7% | 0.0 |
| FC2B (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| FR2 (L) | 1 | ACh | 3.5 | 0.6% | 0.0 |
| P6-8P9 (L) | 2 | Glu | 3.5 | 0.6% | 0.4 |
| PFNm_a (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| LAL190 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| PFR_b (L) | 1 | ACh | 2.5 | 0.4% | 0.0 |
| ExR4 (R) | 1 | Glu | 2.5 | 0.4% | 0.0 |
| ER6 (R) | 2 | GABA | 2.5 | 0.4% | 0.2 |
| ER1_b (R) | 2 | GABA | 2 | 0.3% | 0.5 |
| OA-AL2i1 (L) | 1 | unc | 1.5 | 0.2% | 0.0 |
| FS4A (L) | 2 | ACh | 1.5 | 0.2% | 0.3 |
| FB4C (R) | 1 | Glu | 1.5 | 0.2% | 0.0 |
| SpsP (L) | 2 | Glu | 1.5 | 0.2% | 0.3 |
| ExR6 (L) | 1 | Glu | 1.5 | 0.2% | 0.0 |
| FC3_a (L) | 2 | ACh | 1.5 | 0.2% | 0.3 |
| FS4C (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| ExR1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| FC1E (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| DNpe014 (L) | 2 | ACh | 1 | 0.2% | 0.0 |
| FC3_c (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| ExR4 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| EPG (R) | 2 | ACh | 1 | 0.2% | 0.0 |
| FB4G (R) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| hDeltaB (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FS3_d (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FS1A_a (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FS2 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| vDeltaK (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| vDeltaM (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| CB4201 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FC1C_a (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FC1D (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FB1A (R) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| hDeltaB (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FC2C (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| PFNm_b (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| ER3p_a (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ER3a_b (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| EL (R) | 1 | OA | 0.5 | 0.1% | 0.0 |
| hDeltaK (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| WEDPN5 (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| FB1C (L) | 1 | DA | 0.5 | 0.1% | 0.0 |